Analysis of some pharmaceuticals in municipal wastewater of Almadinah Almunawarah
Authors:
- Amjad ShraimAmjad Shraim
- Atef DiabADAtef Diab
- Awadh AlsuhaimiAAAwadh Alsuhaimi
- Esmail NiazyENEsmail Niazy
- Mohammed MetwallyMMMohammed Metwally
- Maan AmadMAMaan Amad
- Salim SioudSSSalim Sioud
- Abdulilah DawoudADAbdulilah Dawoud
Open Access
- 1 February 2017
- journal article
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 10, S719-S729
Abstract
The chemical pollution of water resources is a major challenge facing the humanity in this century. Pharmaceuticals and personal care products (PPCPs) are a group of emerging environmental chemical pollutants distinguished by their bioactivity and high solubility. They may also cause health complications to humans and living organisms. Pharmaceuticals enter the environment, mainly via wastewater and can eventually reach the surface and ground water. Despite this, PPCPs received less attention as environmental pollutants than other chemical pollutants (e.g. heavy metals and pesticides). The purpose of this work was to investigate the presence of some of the most frequently dispensed drugs for the residents of Almadinah Almunawarah, Saudi Arabia in the municipal wastewater before and after treatment. For this purpose, wastewater samples were collected biweekly from the city's sewage treatment plant for a period of 4months and analyzed the targeted drugs using tandem LC–MS. Out of the 19 investigated drugs, 5 pharmaceuticals have been found in concentrations greater than the limit of detection in both the influents and effluents of the sewage treatment plant. As expected, the concentrations of investigated pharmaceuticals in the wastewater were found to be low. These drugs and their average concentrations (in ngmL−1) in the influents were: acetaminophen (38.9), metformin (15.2), norfluoxetine (7.07), atenolol (2.04), and cephalexin (1.88). Meanwhile, the effluents contained slightly lower levels (in ngmL−1) than those of influents: acetaminophen (31.2), metformin (3.19), norfluoxetine (7.25), atenolol (0.545), and cephalexin (1.53). The results of this study supported by many other investigations indicate the inefficiency of current conventional wastewater treatment protocols in eliminating such a group of active and potentially hazardous pollutants from the wastewaterKeywords
This publication has 34 references indexed in Scilit:
- Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of ValenciaChemosphere, 2012
- Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewaterWater Research, 2011
- Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river waterJournal of Hazardous Materials, 2009
- Fate of pharmaceuticals and personal care products in wastewater treatment plants – Conception of a database and first resultsEnvironmental Pollution, 2009
- Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatmentWater Research, 2009
- An LC–MS method for the determination of pharmaceutical compounds in wastewater treatment plant influent and effluent samplesTalanta, 2008
- Are we about to upgrade wastewater treatment for removing organic micropollutants?Water Science & Technology, 2008
- Special Characteristics of Pharmaceuticals Related to Environmental FateChemInform, 2005
- Tracking persistent pharmaceutical residues from municipal sewage to drinking waterJournal of Hydrology, 2002
- Occurrence of drugs in German sewage treatment plants and riversWater Research, 1998